Skip to main content
. 2021 May 7;27(8):951–962. doi: 10.1111/cns.13649

FIGURE 1.

FIGURE 1

Beta‐2 microglobulin (B2M) mRNA levels in tumors and corresponding normal tissues. (A) B2M mRNA levels in 33 tumor types in the The Cancer Genome Atlas dataset. (B) B2M expression in lower‐grade gliomas (LGGs) and glioblastomas (GBMs) in the Gravendeel dataset